INTRODUCTION
============

Colorectal cancer is one of the most common human malignancies with a high rate of mortality ([@b6-bt-23-128]). Most colorectal cancers are due to lifestyle factors and increasing age, with only a small number of cases due to genetic causes. The majority of patients are diagnosed at an advanced stage so that chemotherapy is required ([@b6-bt-23-128]).

Many studies have shown that coffee consumption in humans is associated with a reduced incidence of a wide variety of cancers, including colon cancer ([@b5-bt-23-128]; [@b12-bt-23-128]; [@b1-bt-23-128]; [@b28-bt-23-128]). Coffee has been reported to exert its preventive effects against oxidative stress and DNA damage ([@b14-bt-23-128]). Animal studies also support the hypothesis that coffee has chemoprotective effects ([@b26-bt-23-128]; [@b22-bt-23-128]; [@b3-bt-23-128]). The epidemiology of colorectal cancer provides the most supportive evidence of a potential coffee-dependent protection ([@b3-bt-23-128]).

Coffee beans contain more than a thousand of compounds ([@b21-bt-23-128]). One compound in coffee that may be responsible for these benefits is kahweol. It is fat-soluble compounds known as diterpene molecules, which are present in oil derived from *Arabica coffee beans* ([@b13-bt-23-128]). It has been reported that kahweol possess antioxidant and antitumor activities ([@b14-bt-23-128]; [@b10-bt-23-128]; [@b15-bt-23-128]). Although kahweol has been shown to induce apoptosis in human breast tumor cells ([@b2-bt-23-128]), the underlying mechanism in colorectal cancer cells is not known.

Heat shock proteins (HSPs) are molecular chaperones that prevent cell death. They are transiently induced by stress in normal cells and are often constitutively overexpressed in tumors ([@b11-bt-23-128]). HSPs have been classified into the HSP60, HSP70, HSP90, and the small HSP family based on their molecular weight. It has been shown that especially, HSP70 contributes to cell survival and resistance to chemotherapy via multiple anti-apoptotic functions in colorectal cancer cells ([@b17-bt-23-128]; [@b4-bt-23-128]; [@b23-bt-23-128]). It has been also reported that inducible HSP70 interferes the anticancer drug-induced apoptosis ([@b16-bt-23-128]). Furthermore, HSP70 RNA interference (RNAi) significantly suppressed HT-29 human colorectal cancer cell growth both *in vitro* and *in vivo* ([@b29-bt-23-128]). Therefore, inhibiting the expression and function of HSP70 might offer a potential anticancer therapeutic strategy in the treatment of cancers.

In this study, we assessed the antitumor effects of four major components of coffee and elucidated the effects of one of them, kahweol, on apoptosis and HSP70 expression in human colorectal cancer cells.

MATERIALS AND METHODS
=====================

Cell culture and chemicals
--------------------------

HT-29 human colorectal cancer cells, which were obtained from the Korean Cell Line Bank, were cultured in Dulbecco's modified Eagle's medium (Hyclone Laboratories, Inc., Logan, UT, USA) with 10% fetal bovine serum (Hyclone Laboratories, Inc., Logan, UT, USA), 100 U/mL penicillin, and 100 mg/mL streptomycin at 37°C in a 5% CO~2~ humidified atmosphere. Caffeine, chlorogenic acid, caffeic acid, and triptolide were purchased from Sigma-Aldrich (St. Louis, MO, USA) and kahweol was acquired from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). These compounds were dissolved in dimethylsulfoxide (DMSO) and added to cell cultures at the desired concentrations.

Microscopic analysis
--------------------

The HT-29 cells were exposed to the indicated concentrations (control, 100 μM, and 200 μM) of kahweol, and morphological changes were monitored for 6 h. The photographs were taken with a phase contrast microscope (Olympus equipped with Canon camera) at 100× magnification.

Transient transfection of heat shock protein 70
-----------------------------------------------

HSP70 was transiently transfected into HT-29 cells using LT-1 (Mirus Bio, Madison, WI, USA) transfection reagent according to the manufacturer's protocol. Two days after transfection, cells were treated with kahweol or vehicle control, respectively, for 24 h.

Cell viability assay
--------------------

Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. First, HT-29 cells (5×10^5^) were incubated in 12-well plates and treated with various concentrations of kahweol for 20 h at 37°C. Subsequently, MTT (5 mg/mL) was added to each well and incubated for 1 h. Finally, the resulting formazan crystals were dissolved in DMSO and the optical density of each well was measured at 540 nm using a microplate reader (Molecular Devices, Sunnyvale, CA, USA). The results were expressed as a percentage of surviving cells over control cells.

Lactate Dehydrogenase (LDH) activity assay
------------------------------------------

Release of lactate dehydrogenase (LDH) is an *in vitro* marker of cellular toxicity. HT-29 cells were treated with various concentrations of kahweol for 20 h, and then the supernatant was used to assay LDH activity, according to the manufacturer's instruction (Roche Diagnostic Systems, Montclair, NJ, USA).

Western blot analysis
---------------------

HT-29 cells were cultured with the aforementioned compounds for 16 h, and then cell lysates were prepared with lysis buffer. Equal amounts of protein were separated on 10% sodium dodecyl sulfate-polyacrylamide gels. Then, proteins were transferred to Hypond polyvinylidene fluoride membranes (Amersham Biosciences, Piscataway, NJ, USA) and blocked in 5% skim milk in Tris-buffered saline with 0.1% Tween-20 for 1 h at room temperature. Antibodies against cleaved caspase-3 (1:500; Cell Signaling Technology, Danvers, MA, USA), cleaved poly (ADP-ribose) polymerase (PARP) (1:1,000), Bcl-2 (1:1,000), phosphorylated Akt (1:1,000), total Akt (1:1,000), HSP70 (1:1,000), and β-actin (1:2,500; Sigma-Aldrich, Saint Louis, MO, USA) were diluted in 5% skim milk.

Statistical analysis
--------------------

All data are expressed as means ± standard deviation (SD). Statistical significance was analyzed by two-tailed Student's t-test (SPSS version 12.0, SPSS, Inc., Chicago, IL, USA). Data with values of *p*\<0.05 were considered as statistically significant. Single (\*), double (\*\*) and triple (\*\*\*) marks represent statistical significance in *p*\<0.05, *p*\<0.01 and *p*\<0.001, respectively.

RESULTS
=======

Kahweol suppresses cell viability in HT-29 cells
------------------------------------------------

Given the previous reports that coffee beans possess anti-tumor effects ([@b5-bt-23-128]; [@b12-bt-23-128]), cytotoxic property of active compounds of coffee beans such as caffeic acid, caffeine, chlorogenic acid, and kahweol was examined in HT-29 human colorectal cancer cells ([Fig. 1](#f1-bt-23-128){ref-type="fig"}). Noticeable changes in the viability of HT-29 cells were not observed up to 200 micromolar concentrations of caffeic acid, caffeine, and chlorogenic acid. In contrast, kahweol exhibited a significant cytotoxic effect in HT-29 cells in a concentration-dependent manner.

Kahweol induces morphological changes and exhibits cytotoxicity in HT-29 cells
------------------------------------------------------------------------------

In accordance with the cytotoxicity result in [Fig. 1](#f1-bt-23-128){ref-type="fig"}, kahweol ([Fig. 2A](#f2-bt-23-128){ref-type="fig"}) induced cell rounding and detachment in a concentration-dependent manner ([Fig. 2B](#f2-bt-23-128){ref-type="fig"}). No morphological changes were observed in cells treated with vehicle control ([Fig. 2Ba](#f2-bt-23-128){ref-type="fig"}). In contrast, cell rounding and detachment were observed in kahweol-treated cells in a concentration-dependent manner (100 μM ([Fig. 2Bb](#f2-bt-23-128){ref-type="fig"}) and 200 μM ([Fig. 2Bc](#f2-bt-23-128){ref-type="fig"}). To quantitatively measure the amount of kahweol-induced cytotoxicity in HT-29 cells, MTT and LDH release assays were carried out. Kahweol significantly suppressed the viability of HT-29 cells and increased the LDH release in concentration-dependent manners ([Fig. 2C, D](#f2-bt-23-128){ref-type="fig"}).

Kahweol activates caspase-3 and suppresses anti-apoptotic factors in HT-29 cells
--------------------------------------------------------------------------------

To understand how kahweol suppresses the cell viability of HT-29 cells, we examined its effects on the expression levels of several key proteins involved in apoptosis. Kahweol increased the expression of activated caspase-3, a pro-apoptotic enzyme, and cleaved PARP in a concentration-dependent manner ([Fig. 3A](#f3-bt-23-128){ref-type="fig"}). In contrast, kahweol significantly decreased the expression of two anti-apoptotic proteins, Bcl-2 and phosphorylated Akt, in a concentration-dependent manner ([Fig. 3A](#f3-bt-23-128){ref-type="fig"}).

Kahweol attenuates heat shock protein 70 expression in HT-29 cells
------------------------------------------------------------------

Since HSPs are often overexpressed in tumors and promote their growth ([@b6-bt-23-128]; [@b11-bt-23-128]), we examined the effect of kahweol on the expression level of HSP70 in HT-29 cells. Kahweol significantly suppressed HSP70 expression in a concentration-dependent manner ([Fig. 3B](#f3-bt-23-128){ref-type="fig"}).

Heat shock protein 70 activity influences kahweol-induced cytotoxicity in HT-29 cells
-------------------------------------------------------------------------------------

To determine the importance of HSP70 in kahweol-induced cytotoxicity, we measured the viability of HT-29 cells with either downregulated or upregulated HSP70 activity in HT-29 cells treated with kahweol. Pretreatment with triptolide, a HSP70 inhibitor, increased kahweol-induced cytotoxicity ([Fig. 4](#f4-bt-23-128){ref-type="fig"}), whereas transient overexpression of HSP70 significantly reduced cytotoxicity ([Fig. 5A](#f5-bt-23-128){ref-type="fig"}). Increased expression of HSP70 was observed with transient transfection of HSP70 construct ([Fig. 5B](#f5-bt-23-128){ref-type="fig"}). Expression of HSP70 significantly decreased the expression of activated caspase-3 and cleaved PARP and increased the expression of Bcl-2 and phosphorylated Akt ([Fig. 5C](#f5-bt-23-128){ref-type="fig"}). Collectively, these results suggest that HSP70 plays an important role in kahweol-induced cytotoxicity.

DISCUSSION
==========

Previous studies revealed that coffee consumption had the chemopreventive effect in colorectal cancer, and several bioactive compounds showed the pharmacological effectiveness ([@b25-bt-23-128]; [@b8-bt-23-128]). The present study demonstrated that kahweol, the coffee deterpene, significantly suppressed the viability of HT-29 human colorectal cancer cells. Kahweol inhibits HT-29 cell growth via caspase-mediated apoptosis. Kahweol also significantly attenuated the expression of HSP70. Inhibition of HSP70 function with triptolide potentiated kahweol-induced cytotoxicity. And, over-expression of HSP70 lessened the kahweol-induced cytotoxicity in HT-29 cells, suggesting that HSP70 plays a significant role in kahweol-induced cytotoxicity in HT-29 cells.

Among several coffee compounds, kahweol has been reported to possess antitumor and chemoprotective properties in many studies ([@b3-bt-23-128]; [@b24-bt-23-128]; [@b2-bt-23-128]). Although kahweol induces cell death in various human tumor cells such as lung, breast, and leukemia, its underlying mechanism by which kahweol exerts its pro-apoptotic effects has not been clearly demonstrated in human colorectal cancer cells. In the present study, kahweol showed cytotoxicity in HT-29 colon cancer cells and exhibited increased activation of caspase-3 and concurrent suppression of anti-apoptotic components such as Bcl-2 and phosphorylated Akt in HT-29 cells. Our results are consistent with previous reports that kahweol activates pro-apoptotic caspases, such as caspases 3/7 and 9, in human breast tumor cells ([@b2-bt-23-128]) and inhibits anti-apoptotic proteins, such as Bcl-2 and phosphorylated Akt, in human leukemia cells ([@b15-bt-23-128]).

It has been reported that HSPs are often overexpressed in tumors and promote their growth ([@b6-bt-23-128]; [@b11-bt-23-128]; [@b20-bt-23-128]). Especially, HSP70 is often constitutively overexpressed in human colorectal cancer cells ([@b6-bt-23-128]; [@b11-bt-23-128]), and high expression of HSP70 is associated with resistance to chemotherapy ([@b17-bt-23-128]; [@b4-bt-23-128]; [@b23-bt-23-128]). Furthermore, knockdown of HSP70 exhibited significant reduction in cell growth ([@b20-bt-23-128]). Both *in vivo* and *in vitro* animal studies showed that inhibition of HSP70 has antitumor effect against colon cancer ([@b7-bt-23-128]; [@b18-bt-23-128]). The present data demonstrated that treatment of kahweol significantly suppressed the expression of HSP70 in a concentration-dependent manner in HT-29 cells. The finding that triptolide, a HSP70 inhibitor, increases kahweol-induced cytotoxicity is in agreement with its ability to inhibit the growth and metastatic potential of various cancers, including colon cancer ([@b27-bt-23-128]; [@b9-bt-23-128]). Triptolide is known to inhibit the growth and metastasis of various cancer cells, including colon cancer in *in vivo* studies and HSP70 inhibition is considered to play an important role in antitumor effect of triptolide ([@b27-bt-23-128]; [@b9-bt-23-128]). Furthermore, our observation that HSP70 overexpression reduces the expression of pro-apoptotic factors and increases the expression of anti-apoptotic factors suggests that HSP70 suppresses kahweol-induced cell death in HT-29 cells. This is consistent with previous reports that inhibition of HSP70 has antitumor effects against colon cancer ([@b7-bt-23-128]; [@b18-bt-23-128]). Overexpression of HSP70 also exhibited increased phosphorylation of Akt. Previously, it has been reported that HSP70 plays an essential role in the activation of phosphatidylinositol-3-kinase (PI3K)/Akt signaling pathway in endothelial cells ([@b19-bt-23-128]). Further studies are necessary to provide an exact mechanism by which HSP70 regulates Akt phosphorylation in HT-29 cells. Another limitation of the present study is that cytotoxic effect of kahweol might be limited to in HT-29 colon cancer cells. The examination of antitumor activity of kahweol in multiple colon cancer cell models including HCT116 and SW480 cells would provide extensive information of kahweol in colon cancers. Therefore, it is necessary in the future. The present data strongly suggest that HSP70 plays an important role in kahweol-induced cytotoxicity of HT-29 cells. Since HSP70 interferes with chemotherapy-induced apoptosis ([@b16-bt-23-128]), a combination of kahweol and a HSP70 inhibitor may be an effective therapeutic agent for colorectal cancer. However, due to the *in vitro* nature of this study, further research in animal or preclinical studies is needed to confirm our findings, elucidate additional mechanisms of kahweol activity, and investigate its clinical potential.

In conclusion, we have shown that kahweol significantly inhibits colorectal tumor cell growth by promoting apoptosis. Kahweol exerts its pro-apoptotic properties presumably by suppressing HSP70 expression. The present study strongly suggests that kahweol might be a potential antitumor agent as a HSP70 inhibitor in colorectal cancers. However, the exact mechanism by which kahweol suppresses HSP70 expression may need further studies.
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![Cytotoxic profiles of bioactive compounds from coffee beans in HT-29 human colorectal cells. HT-29 cells were incubated with caffeic acid, caffeine, chlorogenic acid, or kahweol for 24 h and cell viability was examined using MTT assay. Results are expressed as the mean ± SD of three or more independent experiments. \**p*\<0.05, \*\**p*\<0.01, and \*\*\**p*\<0.001 vs. control.](BT-23-128f1){#f1-bt-23-128}

![Chemical structure of kahweol (A) and effects of kahweol on the morphology (B) and cytotoxicity (C, D) in HT-29 human colorectal cancer cells. B. Cells were treated with kahweol at the indicated concentrations (control (a), 100 μM (b), and 200 μM (c)) for 6 h, and then morphological changes were assessed using an inverted phase contrast microscope. Images are shown at 100× magnification. C, D. Cells were treated with kahweol for 24 h, and then cell viability was measured by MTT (C) and lactate dehydrogenase release (D) assays. Results are expressed as the mean ± SD of three or more independent experiments. \**p*\<0.05, \*\**p*\<0.01, and \*\*\**p*\<0.001 vs. control.](BT-23-128f2){#f2-bt-23-128}

![Effect of kahweol on the expression of apoptosis-related proteins (A) and HSP70 (B) in HT-29 cells. Cells were treated with the indicated concentrations of kahweol for 16 h, and then the expression levels of cleaved caspase-3, poly (ADP-ribose) polymerase (PARP), Bcl-2, phosphorylated Akt (p-Akt), total Akt, and HSP70 were determined by Western blot analysis. β-actin was used as a loading control.](BT-23-128f3){#f3-bt-23-128}

![Effects of triptolide, a HSP70 inhibitor, on cell viability in kahweol-treated HT-29 cells. Cells were pretreated with triptolide (10 μM), and then incubated with the indicated concentrations of kahweol for 48 h, and then cell viability was measured by MTT. Results are expressed as the mean ± SD of three or more independent experiments. \**p*\<0.05, \*\**p*\<0.01, and \*\*\**p*\<0.001 vs. control.](BT-23-128f4){#f4-bt-23-128}

![Effect of HSP70 overexpression on kahweol-induced apoptitic cytotoxicity in HT-29 cells. A. Cells were transiently transfected with HSP70, and then incubated with the indicated concentrations of kahweol for 24 h. Cell viability was measured by MTT. B. The expression level of HSP70 was determined by Western blot analysis. Compared with cells transfected with vehicle (control), HSP70 expression was significantly elevated in HSP70-transfected cells. C. HSP70 overexpression significantly reduced the expression of caspase-3 and PARP and increased the expression of Bcl-2 and p-Akt. β-actin was used as a loading control. Results are expressed as the mean ± SD of three or more independent experiments. \**p*\<0.05, and \*\**p*\<0.01 vs. control.](BT-23-128f5){#f5-bt-23-128}
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